ESR1 and breast cancer: While the role of sumoylation remains poorly understood in the context of breast cancer (62), it has been previously shown that estrogen resistant models harboring mutations in the LBD of ERα exhibit reduced sumoylation and consequent increased transcriptional activity (63).